CMAJ. 2000 Jan 25;162(2):216-20.

The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach.

Holbrook AM, Crowther R, Lotter A, Cheng C, King D.

Source

Centre for Evaluation of Medicines, St. Joseph's Hospital, Hamilton, Ont. holbrook@mcmaster.ca

Abstract

Insomnia, or the dissatisfaction with the quantity, quality or timing of sleep, is a common complaint. Because the definition of "normal" sleep is not well established, the estimates of the prevalence and severity of insomnia vary widely. Insomnia is often secondary to underlying psychiatric and medical conditions, and these should be evaluated and treated as a first measure. Nonpharmacological interventions for insomnia including sleep hygiene manoeuvres and exercise are recommended, although the success of these interventions has not been well documented. Benzodiazepines have been the pharmacologic agents of choice for the treatment of insomnia, but there is reason to exercise caution with their use; their overall benefit compared with placebo appears to be minor, and they are often associated with adverse cognitive effects. Unfortunately, no other class of drugs has proven to be superior to the benzodiazepines in terms of benefit:risk ratio. Given the importance of sleep for health and normal daily functioning the diagnosis, prognosis and treatment of insomnia should be a research priority.

PMID:: 10674058; [PubMed - indexed for MEDLINE]
PMCID:: PMC1232275

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Benzodiazepines

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

[A connection between insomnia and psychiatric disorders in the French general population]. [Encephale. 2002]
[A connection between insomnia and psychiatric disorders in the French general population].
Ohayon MM, Lemoine P. Encephale. 2002 Sep-Oct; 28(5 Pt 1):420-8.
Review Diagnosis and treatment of insomnia. [Am J Health Syst Pharm. 2008]
Review Diagnosis and treatment of insomnia.
Passarella S, Duong MT. Am J Health Syst Pharm. 2008 May 15; 65(10):927-34.
Review Diagnosis and treatment of insomnia and risks associated with lack of treatment. [J Clin Psychiatry. 1992]
Review Diagnosis and treatment of insomnia and risks associated with lack of treatment.
Nino-Murcia G. J Clin Psychiatry. 1992 Dec; 53 Suppl:43-7; discussion 48-9.
Review Diagnosis and treatment of chronic insomnia: a review. [Psychiatr Serv. 2005]
Review Diagnosis and treatment of chronic insomnia: a review.
Benca RM. Psychiatr Serv. 2005 Mar; 56(3):332-43.
Review Detection and assessment of insomnia. [Clin Ther. 1991]
Review Detection and assessment of insomnia.
Czeisler CA, Richardson GS. Clin Ther. 1991 Nov-Dec; 13(6):663-79; discussion 662.

See reviews... See all...

Cited by 6 PubMed Central articles

Headache (chronic tension-type). [Clin Evid (Online). 2009]
Headache (chronic tension-type).
Krishnan A, Silver N. Clin Evid (Online). 2009 Jul 22; 2009. Epub 2009 Jul 22.
Patients with treatment-resistant insomnia taking nightly prescription medications for sleep: a retrospective assessment of diagnostic and treatment variables. [Prim Care Companion J Clin Psy...]
Patients with treatment-resistant insomnia taking nightly prescription medications for sleep: a retrospective assessment of diagnostic and treatment variables.
Krakow B, Ulibarri VA, Romero EA. Prim Care Companion J Clin Psychiatry. 2010; 12(4).
Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. [Sleep. 2008]
Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group. Sleep. 2008 Jan; 31(1):79-90.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The diagnosis and management of insomnia in clinical practice: a practical evide...
The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach.
CMAJ. 2000 Jan 25 ;162(2):216-20.

PubMed
Psychiatric genetics: back to the future.
Psychiatric genetics: back to the future.
Mol Psychiatry. 2000 Jan ;5(1):22-31.

PubMed
Arsenic trioxide-induced apoptosis and differentiation are associated respective...
Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Leukemia. 2000 Feb ;14(2):262-70.

PubMed
High-dose sequential chemotherapy with recombinant granulocyte colony-stimulatin...
High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
J Clin Oncol. 2000 Feb ;18(4):754-64.

PubMed
c-Kit triggers dual phosphorylations, which couple activation and degradation of...
c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.
Genes Dev. 2000 Feb 1 ;14(3):301-12.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: